Predict your next investment

Yaoshibang company logo
MOBILE & TELECOMMUNICATIONS | Mobile Commerce / Pharmacies
ysbang.cn

See what CB Insights has to offer

Founded Year

2015

Stage

Series E | Alive

Total Raised

$497.19M

Valuation

$0000 

Last Raised

$270M | 4 mos ago

About Yaoshibang

Yaoshibang is an operator of mobile apps that allow patients to order and receive medicine from pharmacies directly, with guaranteed next-day delivery in major cities.

Yaoshibang Headquarter Location

No. 397 Xingang Road TIT Creative Park, Creative West Road C03 Building/C06 Building

Guangzhou, Guangdong,

China

+86 020-89772072

Latest Yaoshibang News

Chinese pharmacy platform Yaoshibang secures $270m funding

Jun 15, 2021

Chinese pharmacy platform Yaoshibang secures $270m funding 15/06/2021 Chinese pharmaceutical trading platform Yaoshibang , also known as Ysbang, has secured $270 million in a fresh round of financing, the company announced on Tuesday. The new round saw participation from the Chinese conglomerate Zhejiang Pearl River Investment Management, search engine giant Baidu, Green Pine Capital Partners, state-backed Guangzhou City Construction Investment’s investment vehicle SF Fund, and undisclosed sovereign wealth funds, and insurance groups. China Renaissance bank facilitated the transaction. Following the investment, Yaoshibang will look to upgrade digital sales, marketing systems, and is data sharing platform. Managed by Guangzhou Sudao Information Technology, Yaoshibang runs as a smart supply chain platform for the pharmaceutical industry. In partnership with Xian Janssen Pharmaceutical, CR Sanjiu, Zhongsheng Pharma, and Scrianen, Yaoshibang integrates an all-in-one internet platform. Through Yaoshibang’s mobile app, retailers, clinics, and individual consumers can order and receive medicines directly from pharmaceutical firms. Yaoshibang also provides courses for trainers who wish to be licensed pharmacists. “Separation of dispensing from prescription propels the transformation of long-standing pharmaceutical industry and retail management in China, alongside nurturing innovative supply chain mechanisms amounting to a trillion yuan ($156 billion),” said China Renaissance Investment banking business managing director and industrial internet director Kun Xu in the statement. Previously in 2018, Yaoshibang had already pocketed $133 million in a Series D round from Tiger Global Management, H Capital and DCM. Its early-stage backers include SIG, China’s smartphone giant Xiaomi’s investment arm Shunwei Capital, ECC Capital, Fosun Pharma, and Ivy Capital. China’s top online pharmacy platforms also consist of Dingdang Health, which had raised $220 million funding led by TPG Capital Asia earlier last week, state-owned Sinopharm’s yao123.com, and Alibaba’s AliHealth, among others. A video game developed by TikTok owner ByteDance was China’s fifth-biggest mobile game by revenue in May, demonstrating the company’s potential as a challenger to Tencent Holdings’ dominance of the lucrative sector. One… Lorena Garcia was in her 20s when she was suddenly struck with crippling pain associated with her menstrual cycles. It was four years before she was diagnosed with endometriosis, a chronic, incurable disease… Hong Kong-listed Cafe de Coral Holdings, one of Asia’s largest restaurant and catering groups operating quick-service restaurants, will speed up its expansion in mainland China with 17 store openings in the pipeline. The… Samsung Galaxy Watch 4 and Watch Active 4 FCC certification revealed some technical details even before their actual launch sometime in August. The filing leaked the connectivity connections, batteries, and wireless chargers of…

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Yaoshibang

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Yaoshibang in 1 CB Insights research brief, most recently on Jan 23, 2020.

Expert Collections containing Yaoshibang

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Yaoshibang is included in 6 Expert Collections, including E-Commerce.

E

E-Commerce

8,739 items

O

On-Demand

1,239 items

P

Pharma Supply Chain

1,258 items

C

China Digital Health Collection

467 items

D

Digital Health

11,245 items

Companies leveraging digital technology for healthcare, consumer health, clinical research, and life science (e.g. biopharma, medtech) applications.

P

Pharma Supply Chain in Healthcare Tech Market Map

99 items

Private companies that are addressing 11 distinct technology priorities across the pharmaceutical supply chain.

Yaoshibang Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Yaoshibang Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.